HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zahra Alsairafi Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2021The perspectives of physicians regarding antidiabetic therapy de-intensification and factors affecting their treatment choices-A cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zahra Alsairafi Research Topics

Disease

3Diabetic Nephropathies (Diabetic Nephropathy)
09/2023 - 01/2019
2Albuminuria
11/2022 - 01/2022
1Kidney Diseases (Kidney Disease)
11/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2022
1Pulmonary Embolism
07/2021
1COVID-19
07/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Diabetes Mellitus
04/2020
1Coma (Comas)
04/2020

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2019
2CreatinineIBA
11/2022 - 01/2022
1Insulin-Like Growth Factor Binding Protein 4IBA
11/2022
1Insulin-Like Growth Factor Binding Protein 1IBA
11/2022
1Insulin-Like Growth Factor Binding Protein 3IBA
11/2022
1Cadherins (E-Cadherin)IBA
01/2022
14- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
07/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2019

Therapy/Procedure

1Length of Stay
04/2020